Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Neurology | Family Medicine
Disease Category: Alzheimer's Disease
Location: United States, NJ

Clinical Trial Details

Overview

Research Study Summary

Alzheimer's disease study for mild to moderate AD.

Purpose

For people with Alzheimer's there's no time to lose.

A research study — ICARA — is now under way to explore a possible new investigational treatment for Alzheimer's disease.

You may be eligible to participate in the ICARA study if you:

  • Are 50 to 88 years old
  • Have a diagnosis of probable Alzheimer's disease
  • In addition to receiving study-related physical exams and laboratory services at no charge, particpants may receive study medication and will be monitored by a medical team, including a nurse or study coordinator and a physician.
  • Ask your doctor if the ICARA study is right for you.

Patient Exclusion Criteria: You are ApoE positive.

To Learn more
Phase

3

Gender

Both Male and Female

Age

50 to 88 Years

Overall Status

Recruiting

Facility Type

N/A

Contact

Marcia Fogle, Clinical Trials Manager
Rowan University School of Osteopathic Medicine
42 East Laurel Road, Suite 1800
Stratford, NJ 08084
Phone: 856-566-6003
Fax: 856-566-2773

View Map

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

CW ID: 159905

Date Last Changed: January 29, 2014


DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.